EMMPRIN has been reported to stimulate tumor angiogenesis via vascular endothelial cell growth factor (VEGF) [22,23], but the correlation of EMMPRIN with the degree of angiogenesis has not been reported, and the roles of EMMPRIN in RCC are unclear. Here, BSG is linked to renal cell carcinoma.